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The combination of an increase in the cAMP-phospho-
diesterase activity of h-prune and its interaction with
nm23-H1 have been shown to be key steps in the induction
of cellular motility in breast cancer cells. Here we present
the molecular mechanisms of this interaction. The region
of the nm23–h-prune interaction lies between S120 and
S125 of nm23, where missense mutants show impaired
binding; this region has been highly conserved throughout
evolution, and can undergo serine phosphorylation by
casein kinase I. Thus, the casein kinase I d-e speciﬁc
inhibitor IC261 impairs the formation of the nm23–h-
prune complex, which translates ‘in vitro’ into inhibition of
cellular motility in a breast cancer cellular model. A
competitive permeable peptide containing the region for
phosphorylation by casein kinase I impairs cellular
motility to the same extent as IC261. The identiﬁcation
of these two modes of inhibition of formation of the nm23-
H1–h-prune protein complex pave the way toward new
challenges, including translational studies using IC261 or
this competitive peptide ‘in vivo’ to inhibit cellular motility
induced by nm23-H1–h-prune complex formation during
progression of breast cancer.
Oncogene advance online publication, 1 October 2007;
doi:10.1038/sj.onc.1210822
Keywords: h-prune; nm23; CKI; motility; IC261
Introduction
The nm23 proteins have been conserved throughout
evolution as they are ubiquitously expressed from bacteria
to mammals. They possess a nucleoside diphosphate kinase
(NDPK) activity that catalyzes transfer of the g-phosphate
from nucleoside triphosphates (NTPs) to NDPs. The
human nm23 gene family is composed of eight members,
with nm23-H1 having a high degree of homology (89%) to
nm23-H2. Nm23-H1 was identiﬁed as a metastasis
suppressor gene (Steeg et al., 1988); in breast carcinoma,
nm23 overexpression has been linked to early stages of the
cancer, with loss of expression in more advanced cases. The
human nm23 genes have regulatory roles in cell prolifera-
tion, embryonic development, apoptosis, differentiation
and tumor metastasis (Lacombe et al., 2000; Lascu, 2000).
However, the NDPK activity alone cannot explain these
pleomorphic effects. The nm23 proteins have been reported
to possess both a histidine protein kinase activity and a
phosphotransferase activity; the latter potentially represents
an additional mechanism by which the nm23s can inﬂuence
the metastasis and differentiation processes (MacDonald
et al., 1996; Wagner et al., 1997). To date, several nm23
interactors have been described in mammals, including
Rad, Tiam1, Arf6, the nucleosome assembly protein SET,
Cdc42, EBNA1 and KSR (Otsuki et al., 2001; Tseng et al.,
2001; Palacios et al., 2002), although their roles are not
fully understood. AMPKa1, a heterotrimeric kinase that is
a sensor of cellular energy status, binds to and phosphor-
ylates nm23-H1, which in turn channels the ATP produced
by its enzymatic activity to AMP activated kinase (AMPK)
(Crawford et al., 2005, 2006).
An additional partner of the nm23 protein is seen in
h-prune, the human homolog of the Drosophila prune
protein (Reymond et al., 1999; Forus et al., 2001;
D’Angelo et al., 2004). In Drosophila, a single copy
mutation of proline 97 to serine in the awd gene is lethal
in the genetic background of the prune gene, which is
known as the Killer-of-Prune phenotype. Together with
h-prune, the Drosophila prune protein belongs to the
DHH superfamily of phosphoesterases, which includes
the RecJ nuclease and pyrophosphatases from bacteria
and yeast (Aravind and Koonin, 1998).
We have previously shown that ampliﬁcation of h-prune
copy number induces cell proliferation in an established
breast cancer cellular model (Reymond et al., 1999), and we
showed that this occurs through its cAMP-phosphodiester-
ase (PDE) activity (D’Angelo et al., 2004). Additionally,Received 17 July 2006; revised 9 August 2007; accepted 28 August 2007
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gene expression proﬁle analyses have been indicating how
several genes involved in cell motility are upregulated in the
MDA-MB-435 c100 breast cancer models (D’Angelo and
Zollo, 2004; Steeg, 2005). H-prune overexpression and
nm23-H1–h-prune complex formation have a positive
inﬂuence on cell motility, which suggests a role for h-prune
in metastasis formation (D’Angelo and Zollo, 2004). In our
ﬁrst analyses on a large set of breast tumors, the pro-
motility effects seen in vitro translated in vivo to signiﬁcant
association with lymph node status and metastasis forma-
tion, thus indicating that h-prune provides a new marker of
advanced stage disease in breast carcinoma (Zollo et al.,
2005).
It has been previously shown that in vitro nm23-H1
and nm23-H2 can be phosphorylated on S122 by casein
kinase II (CKII) (Engel et al., 1994; Biondi et al., 1996),
thus affecting their NDPK activity; additionally, the
Drosophila protein with the S122A substitution is not
phosphorylated. It is known that the mammalian CKI
isoforms (a, b1, b2, g1, g2, d, e) can phosphorylate many
different substrates, among which there are key reg-
ulatory proteins involved in control of cell proliferation
and differentiation, crucial events during cancer pro-
gression (Knippschild et al., 2005).
We demonstrate here that the S122 and S125 serine
residues of nm23-H1 and nm23-H2 are phosphorylated
by CKI. Further, the speciﬁc CKId-e inhibitor IC261
and our speciﬁc permeable peptide that mimics the
nm23-H1 region of interaction with h-prune both
disrupt the formation of the nm23-H1–h-prune protein
complex. This results in inhibition of cell motility effects
mediated via h-prune overexpression. These data have
the potential to be used for ‘translational studies’ in vivo
to reduce metastases formation arising from h-prune
overexpression.
Results
Mapping the region of interaction between nm23-H1
and h-prune
Here, we ﬁrst aimed to identify the interaction region
between h-prune and nm23. An afﬁnity chromatography
approach was applied that uses the puriﬁed recombinant
h-prune protein. Nm23-H1 cDNA was fragmented into
four overlapping regions (see Materials and methods)
and transfected into COS-7A cells; the protein extracts
from these were applied to a Ni-NTA afﬁnity column on
which the recombinant h-prune protein had been
preadsorbed. The eluted fractions were then analysed
by western blotting: the nm23 protein fragment denoted
as ‘region 4’ bound to the full-length h-prune protein.
This is a region highly conserved in other species (see
Figures 1a–c); no binding was seen for regions 1 and 2 of
nm23, and there was only a weak interaction for region
3. To verify the results of the immunoprecipitation in
living mammalian cells, we used ﬂuorescent protein
translocation biosensors (Knauer and Stauber, 2005).
This method uses a nucleolus translocation amino-acid
sequence to translocate a protein into the nucleolus. If
binding occurs with the expressed protein, the transloca-
tion biosensor will detect it in the nucleolus. We thus
expressed three overlapping regions of the nm23-H1
protein as green ﬂuorescent protein (GFP)-prey_mdm2
fusions (Figure 1d). As expected, upon co-expression in
HeLa and 293 cells, the GFP-prey_mdm2 fusions
localized to the cytoplasm and did not colocalize with
the empty blue ﬂuorescence protein (BFP) bait in the
nucleolus (data not shown). Next, we expressed the open
reading frame (ORF) of the h-prune protein in the
context of the BFP-bait construct. Upon transfection,
the p53-bait fusions were correctly tethered to the
nucleolus. However, only GFP-prey_H1B and _H1C
induced the cytoplasm-to-nucleus translocation of the
h-prune_BFP-bait, indicative of an efﬁcient in vivo
protein interaction (Figures 1d and e). Notably, GFP-
prey_H1C was not tethered completely to the nucleolus
by the bait, while GFP-prey_H1B was, indicative of a
weaker interaction of H1C with the h-prune protein. No
translocation was seen with GFP-prey_H1A. Similar
results were obtained in 293 cells (data not shown).
Interestingly, this region is highly conserved in the nm23
proteins across other species. We thus cloned the nm23
homologs from Danio rerio, Caenorhabditis elegans,
Drosophila melanogaster and Xenopus laevis and expres-
sed them in COS-7A cells, with the extracted proteins
used in immunoprecipitation assays (see Supplementary
material, Supplementary Figures 1SA–D). Our results
indicate that the carboxyl terminus of nm23-H1 (aa
113–152) is primarily responsible for its interaction with
h-prune.
The nm23–h-prune interaction is due to serine
phosphorylation of nm23
Through bioinformatic predictions, the nm23-H1 and
nm23-H2 regions spanning from S120 to S125 have high
probability scores for phosphorylation by CKI and
CKII. Additionally, the serine residue in position 125
has a perfect match with the S(p)-x-x-S consensus
pattern identiﬁed for CKI. Of note, the amino-terminal
serine must be phosphorylated before the C-terminal
serine residue is phosphorylated (Kuret et al., 1985; Fiol
et al., 1988). The phosphorylation of nm23 has already
been demonstrated, with S122 serine phosphorylation
by CKII occurring in vitro (Engel et al., 1994). From our
co-immunoprecipitation analyses, the single point muta-
tions in positions S122 and S125 of nm23-H1 both
impaired its interaction with h-prune (see Supplemen-
tary Figures 2SA–D). Conversely, a missense mutation
in S44, a residue already seen to be phosphorylated in
human nm23, did not impair the nm23–h-prune inter-
action (Reymond et al., 1999), thus indicating that if
phosphorylation is involved in nm23–h-prune binding, it
is speciﬁc to the S120-S125 stretch of nm23. Further,
considering that the CKI phosphorylation mechanism
requires serine prephosphorylation at the ‘upstream’
serine of the consensus sequence, these S120 or S122
serines should prime the phosphorylation in position
S125, and this latter phosphorylation should, in turn,
regulate the interaction of nm23 with h-prune. To test
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these hypotheses, we performed ‘in vitro’ phosphoryla-
tion assays using wild-type nm23-H1 (see Figures 2a–c)
and standard mass spectrometry analysis (see Material
and methods). We identiﬁed two phosphopeptides, one
with a doubly charged m/z of 783.3 lost this phosphate
group (49Da as neutral loss) during collision-induced
dissociation (CID), to form a doubly charged fragment
with an m/z of 734.3. The speciﬁc multiple reaction
monitoring (MRM) transition method (Q1¼ 783.3 and
Q3¼ 734.3) was thus used to detect this phosphopep-
tide. The interpretation of the MS/MS spectrum of the
precursor ion at m/z 783.3 led to reconstruction of the
sequence NIIHGSDSVESAEK, corresponding to pep-
tides 115–128 within the nm23-H1 protein sequence
(Figure 2a). The mass difference indicated the occur-
rence of a phosphorylation site at the level of S122;
S120 and S125 were unmodiﬁed. The spectral analysis
revealed another doubly charged (2þ ) signal at m/z
823.27, identiﬁed as the same 115–128 peptide that was
modiﬁed with two phosphate groups at levels of both
S122 and S125, with no modiﬁcations seen on S120. The
phosphomodiﬁcation on S122 occurs outside of the
consensus sequence, a phenomenon that has been
described for other casein kinase substrates (Marin
et al., 1994, 2003).
We then investigated the ability of different isoforms
of CKI to phosphorylate nm23-H1 in vitro (see Material
and methods) using the recombinant proteins listed in
Figure 2b. The rates of phosphate incorporation ranged
from 0.44 to 2.5 nmol per mg of recombinant casein
kinase. A CKI control peptide showed incorporation
levels from 20 to 100 nmolmin1mg1. The stoichiome-
try of the phosphate incorporation for CKIe was
calculated as 0.01 pmol phosphate per pmol nm23-H1
per min. For CKId, this value dropped to 0.002 pmol
phosphate per pmol nm23-H1 per min. Thus, CKIe is
more efﬁcient in its ability to phosphorylate nm23, with
CKId showing a lower incorporation rate. We also
determined the kinetic parameters of the phosphoryla-
tion of nm23-H1 by CKIe and CKId, as illustrated in
Figure 2c, where CKIe displayed a higher afﬁnity (lower
Km; 0.14 mM) versus nm23-H1, as compared to CKId
(3.38 mM).
The phosphorylated and nonphosphorylated forms of
nm23 were then tested for their binding to recombinant
h-prune in an in vitro binding assay. Here, the nm23–h-
prune interaction occurred only with the wild-type nm23
protein that had been previously phosphorylated by
CKI. All of the single mutations to S120, S122 and
Figure 1 Mapping of the h-prune–nm23 interaction domain. (a)
Schematic representation of the nm23 protein regions used in the
in vitro immunoprecipitation assays. The sequence of region 4 that
mediates the binding of nm23 with h-prune is shown. (b) Alignment
of region 4 of nm23-H1 in different species. Gray shading shows
residue identity between different species. The three serine residues,
S120, S122 and S125, are strongly conserved (black dots). (c) The
HA-tagged nm23 protein fragments, cloned in an HA pcDNA
vector, were used to map the h-prune interaction region. Left:
western blotting of total cell lysates (20 mg) from COS-7A cells
transfected with the constructs carrying the cDNAs coding for the
different regions, revealed by an anti-HA monoclonal antibody
(Roche, Basel, Switzerland). Right: 1mg of 6His tagged h-prune
recombinant protein was incubated with Ni-NTA agarose mag-
netic beads for 1 h. Then 40mg of the total cell lysates (left panel)
was incubated with h-prune linked to the magnetic beads. After
washes, the elution was performed with imidazole and the eluates
were tested for the presence of both h-prune and the nm23-H1
regions with the A59 polyclonal antibody (Apotech-Alexis.com)
and the anti-HA monoclonal antibody (Roche), as indicated. (d)
Schematic representation of the nm23 protein regions used in the
in vivo PTB mapping protein interaction assay. Bar, 50 amino
acids. (e) PTB-based mapping of the nm23-H1–h-prune protein
interaction interface in living cells. HeLa cells co-expressing the
indicated prey/bait proteins were analysed by ﬂuorescence micro-
scopy for GFP and BFP fusions. Upon co-expression, the GFP-
prey_nm23-H1 fusions (H1A, B, C) localized to the cytoplasm
and did not colocalize with the empty BFP-bait at the nucleolus.
In contrast, co-expression of the nucleolar anchored h-prune
fusion (h-prune_BFP-bait) recruited GFP-prey_H1B (aa 71–152)
and GFP-prey_H1C (aa 41–82) to the nucleolus, indicative of an
efﬁcient in vivo protein interaction. No interaction was observed for
the GFP-prey_H1A (aa 1–80). Representative images are shown,
and similar results were observed in two independent experiments.
Arrow marks nucleolus. Scale bars, 10 mm. c: NLS, b: NES.
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S125 tested prevented the binding between nm23-H1
and h-prune (Figure 2d). Furthermore, to exclude the
possibility that nm23 binding with h-prune is through a
conformational change in nm23, instead of a change in
its phosphorylation status, two other additional single
mutations outside of the region identiﬁed here were
tested: K128G and H135G. Neither of these mutations
disrupted the binding of nm23-H1 with h-prune after its
phosphorylation with CKId (Figure 2e). This thus
indicates that we can exclude the possibility that other
Nm23–h-prune complex formation and cellular motility
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residues that affect the nm23 conformational status
around this region are speciﬁcally involved with its
h-prune interaction.
These ﬁndings do however suggest that the S120
residue is also necessary for nm23 binding with h-prune
(Reymond et al., 1999), although the need for its
phosphorylation was excluded in the interpretation of
the MS/MS spectra, as summarized in Figure 2a. We
believe that this is due to the transient nature of the
phosphorylation of the S120 residue; nevertheless, this
residue would appear to be important for the phosphor-
ylation of the downstream S122 and S125 residues, and
consequently for the interaction between nm23 and h-
prune. Of note, while the data presented in Figures 2d
and e relate speciﬁcally to the nm23-H1–h-prune inter-
actions, identical results were obtained with nm23-H2
(data not shown).
Phosphorylation of nm23 occurs in the S120
to S125 region
Mass spectrometry analyses were used to detect the
phosphorylation of these proteins when transiently
expressed in living cells, followed by immunoprecipita-
tion using an anti-HA-tag antibody. The immunopreci-
pitated HA-nm23-H2 protein was excised from SDS–
polyacrylamide gel electrophoresis gels and analysed via
tryptic digestion and matrix-assisted laser desorption/
ionization–time of ﬂight mass spectrometry. This indi-
cated phosphorylation on S125 and on S122 or S120. Of
note, the peptide at m/z 514.53 that contained both S120
and S122 showed an increase of 80Da (MWtheoretical¼
434.53), which was thus only attributable to a single
phosphorylation event (Figures 2f and g).
As it has been shown that S122 can be phosphory-
lated by CKII (Engel et al., 1994), here we cannot
distinguish between phosphorylation on S120 or S122,
although we do see S125 phosphorylation, and we
believe that S122 phosphorylation can in turn promote
phosphorylation on S125.
We also investigated whether nm23 phosphorylated
by CKI was altered in terms of its oligomerization status
and its NDPK activity, and how its oligomerization
relates to its interaction with h-prune. Using the
recombinant nm23 proteins expressed in Escherichia
coli, the major proportion of nm23-H1 was normally
present as a hexamer (39.7%) and a trimer (56.2%),
although dimers (3.6%) and monomers (0.7%) were
also detected (Figure 3a), as has been described
previously (Kim et al., 2003). The data presented in
Figure 3b show a signiﬁcant increase in the hexameric
structure upon CKI phosphorylation (hexamer, 53.6%;
Pp0.0015; trimer, 42.2%; dimer, 4.1%; monomer, not
detected; through gel ﬁltration performed on the
Figure 2 The nm23–h-prune interaction depends on nm23 phosphorylation in vitro. (a) Nano-LC-mass spectrometry analysis of
nm23-H1 after its in vitro phosphorylation by CKI. Two phosphopeptides were identiﬁed, one carrying one phosphorylation on S125
or two phosphorylations on S122 and S125. (b) Rates of incorporation of [32P] in in vitro kinase assays using the CKI isoforms
indicated, with nm23-H1 as a substrate. NB conducted with 0.1mM ATP. (c) Lineweaver–Burke plots of the phosphorylation of nm23
by CKIe and CKId (10min at 30 1C in the presence of 0.1mM ATP), in gray is shown the intercept of the graph representing 1 km1 of
CKId. (d–e) In vitro binding assay using puriﬁed 6His-tagged h-prune expressed by the baculovirus system, using different 6His-
tagged nm23-H1 protein mutants phosphorylated or not in vitro by the CKId recombinant protein. H-prune was immunoprecipitated
with the A59 polyclonal antibody and both of the proteins were revealed in the pellet by an anti-His-tag antibody (Qiagen,
Germantown, MD, USA). (f) MALDI spectrum of the nm23-H2 tryptic digest. (g) Enlarged portion of the MALDI spectrum of the
nm23-H2 tryptic digest. The signal at m/z 514.53 was assigned to the tryptic fragment 140–143 carrying a phosphate group.
Figure 3 Inﬂuence of CKI phosphorylation on nm23 oligomer-
ization. Multimeric structures formed by nm23-H1 in the absence
(a) and presence of CKI treatment and without (b) or with (c)
h-prune. Recombinant nm23-H1 was treated with CKI for 60min
at 30 1C. Hexamers, trimers, dimers and monomers are visible
following gel ﬁltration. *Pp0.001; #Pp0.002; see also text.
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phosphorylated and nonphosphorylated nm23-H1 re-
combinant protein). Figure 3c shows the effects of
addition of the recombinant h-prune protein to the
reaction mixture. Here, a complex of h-prune and nm23
was eluted at 300 kDa, which was assigned to two
molecules of h-prune and one hexamer of nm23. The
two molecules of h-prune are present as a dimer, as
additionally supported by recent ﬁndings (Middelhaufe
et al., 2007). The presence of both proteins was also
conﬁrmed by western blotting using speciﬁc antibodies
(Figure 3c). We also examined the effects of phosphor-
ylation by CKI on the NDPK activity of nm23-H1
(Supplementary Figure 3S1). These results are reported
in the Supplementary section, and they also support the
preferential binding of h-prune to the hexameric form of
nm23-H1.
The CKI-speciﬁc inhibitor IC261 impairs nm23
phosphorylation and its interaction with h-prune
To investigate regulation of nm23 phosphorylation
in vivo and to determine to what extent this modiﬁcation
inﬂuences its complex formation with h-prune, we raised
a polyclonal antibody in rabbit that preferentially recog-
nizes the phosphorylated versus the nonphosphorylated
forms of nm23. This was achieved by synthesizing a
peptide with a sequence that corresponds to the region
between N115 and E127 of nm23-H1 (see Materials and
methods), and phosphorylated on S122. The antibody
indeed speciﬁcally recognizes only phosphorylated nm23
(Figure 4a). A further characterize of the phosphoepi-
tope antibody show that the S125A mutation completely
abrogated the antibody reactivity, thus suggesting that
the antibody preferentially recognizes the S125 phos-
phoepitope.
To date several CKI inhibitors are known (Rena
et al., 2004), one of which is IC261, an ATP-competitive
inhibitor that is selective for CKId and CKIe (Mash-
hoon et al., 2000). Other two known inhibitors are
D4476 and CKI-7. While the selectivity of D4476 versus
the CKI isoforms has not been deﬁned, CKI-7 inhibitor
is known to act on all CKI isoforms. This thus indicated
the use of IC261, particularly considering its speciﬁcity
toward CKIe and CKId.
The MDA-MB-435-c100 breast cancer cell line that
constitutively expresses nm23-H1 (MDA-MB-H1-177)
(Kantor et al., 1993) was thus treated with IC261, and
total cell lysates were analysed by western blotting. As
illustrated in Figure 4c, after 6–8h of incubation with
IC261 (see also Materials and methods; Cooper and
Lampe (2002) and Li et al. (2004)), the signal intensity of
nm23 phosphorylation decreased by 65% (quantiﬁed by
imaging scan analyses; data not shown). To conﬁrm any
effects of inhibition of CKI on nm23 phosphorylation in
cells and to avoid any misinterpretation relating to the
relatively high levels of IC261 used (see below), here we
also treated the MDA-MB-H1-177 cells with the two
additional CKI inhibitors indicated above: D4476 and
CKI-7 (Figure 4d). These results indicate that (i) the
turnover of nm23-H1 and nm23-H2 phosphorylation by
CKI is very low, and it appears that nm23 is largely
constitutively phosphorylated in living cells (Figures 4c–e);
(ii) these selective inhibitors for CKI abolish the phos-
phorylation of nm23 in the region within N115 to E127
(Figures 4c and d).
In these assays, IC261 was used at a concentration of
50 mM, CKI-7 at 400 mM, and D4476 at 25 mM, according
to the concentrations reported in the literature (Cooper
and Lampe, 2002; Izeradjene et al., 2004; Li et al., 2004;
Rena et al., 2004).
To investigate the speciﬁcity of this phosphorylation
and its inhibition further, we next used a speciﬁc
inhibitor of CKII, 2-dimethylamino-4,5,6,7-tetrabro-
mo-1H-benzimidazole (DMAT) (Pagano et al., 2004).
When we treated the MDA-MB-H1-177 cells with
DMAT, no effects were seen on the levels of phosphor-
ylation of nm23-H1 (Figure 4e), which also provided
further support for the speciﬁcity of our phosphoepitope
antibody, in its speciﬁc recognition of the phosphoryla-
tion occurring on serines S122 and S125 of nm23
promoted by CKI. Then, to exclude possible side effects
of the CKI inhibitors above versus cellular kinases such
as AMPK and protein kinase A (PKA), we tested
whether speciﬁc inhibitors of these kinases would also
affect the phosphorylation of nm23. Here we used
compound C and KT5720 with independent treatments
at 20 and 10 mM, respectively (see literature data
reported by Kim et al., 2002 and Lee et al., 2003), used
with MDA-MB-H1-177 cells; neither of these kinase
inhibitors affected the amounts of nm23 and phos-
phorylated nm23 revealed with the phosphoepitope
antibody (Figure 4f).
To address whether this phosphorylation of nm23
mediates its binding to h-prune, we treated the MDA-
MB-435-c100 cells with IC261 for 6 h (a time-frame
chosen from above; see Figure 4c). The subsequent co-
immunoprecipitation analyses for nm23 and h-prune
revealed that the interaction between these two endo-
genous proteins occurred only in the absence of IC261
(Figure 4g), demonstrating that nm23 phosphorylation
is necessary for its complex formation with h-prune. In
contrast to this loss of complex formation with IC261
treatment, the CKII inhibitor DMAT did not inﬂuence
the nm23–h-prune binding properties in MDA-MB-435-
c100 cells, as shown by immunoprecipitation assays
(Figure 4h).
Of note, the use of a 6-h treatment of the MDA-MB-
435-c100 cells with CKI-7 and D4476 also efﬁciently
impaired the nm23–H-prune interaction (Figure 4i), at
similar levels as seen for IC261, further conﬁrming the
role of CKI in the regulation of this interaction. These
experiments with CKI inhibitors are also useful for the
discrimination between the potential effects of trans-
phosphorylation versus auto-phosphorylation; even if
small levels of nm23 modiﬁcation can be ascribed to
auto-phosphorylation, this basal auto-phosphorylation
is not enough to lead to the formation of revealable
amounts of the nm23–h-prune protein complex, as in
the presence of the CKI inhibitors the nm23–h-prune
interaction is impaired. Finally we were able to detect
both d and e CKI isoforms as nm23 binders (Supple-
mentary Figures 2SE and F). Therefore, when coupled
Nm23–h-prune complex formation and cellular motility
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with the previous in vitro results shown in Figure 2b,
these ﬁndings indicate CKIe as a strong candidate for
the kinase that phosphorylates nm23 in vivo.
Inhibition of nm23–h-prune binding decreases motility
of breast cancer cells
The enhanced cell motility induced by h-prune over-
expression can be ascribed to two concurrent phenom-
ena: ﬁrst, an increase in cAMP-PDE activity, with a
corresponding decrease in cAMP levels in the cells; and
secondly, the formation of the h-prune and nm23
protein complex, which would reduce the amount of
free nm23 in the cell, with nm23 known to be
responsible for the suppression of motility (D’Angelo
et al., 2004).
To test this hypothesis, we treated our MDA-MB-
435-c100, h-prune-overexpressing, stable clones (MDA-
MB-h-prune #3, #4) with IC261, both alone and
together with dipyridamole (the selective h-prune
cAMP-PDE inhibitor) (Figure 5a). In this cell-motility
assay, the presence of IC261 alone substantially
Figure 4 The nm23–h-prune interaction is impaired by IC261 in breast cancer cell lines. (a) Western blotting of recombinant nm23-
H1 and nm23-H2 treated without and with recombinant CKId (as indicated). The K73 polyclonal anti-serum was afﬁnity puriﬁed
using the phosphorylated synthetic nm23 peptide used as immunogen. Total nm23 revealed by the unpuriﬁed K73 antibody. (b) The
phosphoepitope antibody was tested by western blotting for its afﬁnity versus the serine mutants of nm23: COS-7A cells were
transfected with the indicated expression constructs and total cell lysates probed for immunoreactivity. Nm23-H1 S125A mutation
abolishes the immunoreactivity. Total nm23 revealed by the unpuriﬁed K73 antibody. (c) The CKIe and CKId inhibitor IC261 blocks
nm23-H1 phosphorylation in vitro in the MDA-MB-H1-177 clone overexpressing nm23-H1. Western blotting of MDA-MB-H1-177
cells treated with 50mM IC261; total protein extracts analysed after 0, 2, 4, 6, 8 h of treatment for the presence of nm23
phosphorylation, using the afﬁnity-puriﬁed K73 polyclonal antibody against the nm23 phosphorylated synthetic peptide. Lane 6:
protein extracts pretreated with calf intestine phosphatase (CIP) as control. Bottom panel: total nm23 in the protein extracts used in the
immunoprecipitation, using an anti-nm23-H1 monoclonal antibody (Santa Cruz, Santa Cruz, CA, USA). (d) As (c), with two
additional inhibitors of CKI: 400mM CKI-7 and 25 mM D4476, each for 8 h (chosen from the previous time course with IC261,
considering the probably low turnover of the site). (e) As (c), with an inhibitor of CKII: 10mM DMAT for 0, 2, 4, 6 and 8 h. (f) As (c),
with inhibitors of AMPK and PKA, respectively: 20mM compound C and 10mM KT5720 for 2 and 8 h. (g) MDA-MB-435-c100 breast
cancer cell line treated with IC261 for 6 h, as indicated. H-prune was immunoprecipitated from total cell lysates with the A59
polyclonal antibody. The interaction with nm23-H1 was revealed with an anti-nm23-H1 monoclonal antibody (Santa Cruz). (h) As (g),
with an inhibitor of CKII: 10 mM DMAT for 2 h. Immunoprecipitation with an antibody for h-prune; immunoprecipitates were probed
with the unpuriﬁed K73 to detect nm23 in the interaction. (i) As (g), with two additional inhibitors of CKI: 400mM CKI-7 and 25mM
D4476, each for 8 h. Immunoprecipitation and probing as (h).
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decreased the serum-stimulated pro-motility effects of h-
prune overexpression, without affecting that of the
MDA-MB-435-c100 wild-type cells, thus indicating the
speciﬁcity of this effect for cells that express high levels
of h-prune (Figure 5a). As the wild-type cells also
maintained their basal motility when stimulated with
serum, this also indicates that this lowering of cell
motility in the stable clones overexpressing h-prune is
not due to a toxic side effect. Indeed, these cells
remained viable after 6 h of treatment (as evaluated by
trypan blue dye exclusion, data not shown). Of note,
while the PDE inhibitor, dipyridamole also decreased
the serum-stimulated pro-motility effects in these
h-prune overexpressing clones, the addition of both
the CKI and dipyridamole together did not lead to
any additive effects in this cell motility assay system
(Figure 5a). Furthermore, the addition of both IC261
and dipyridamole together at suboptimal levels did not
lead to additive effects in their reduction of cell motility
in these cells overexpressing h-prune (Figure 5b).
We also made use of the cell penetrating region of the
HIV TAT protein. Here it was fused to a peptide
containing the nm23 region phosphorylated by CKI.
This peptide should be able to be phosphorylated by
CKI and consequently to impair the phosphorylation of
the wild-type nm23, thus preventing its interaction with
h-prune see Materials and methods and literature data
(Zhang et al., 2004).
To be certain of this mechanism, we ﬁrst tested
whether the peptide impaired phosphorylation of nm23
with CKI in vitro. Increasing amounts of the peptide did
indeed lower the amount of nm23 phosphorylation by
CKI in a phosphorylation reaction using [g-32P]-ATP
(Figure 5c); in contrast, a scrambled peptide did not
affect nm23 phosphorylation under the same conditions
(Figure 5d). The speciﬁc peptide also impaired the
nm23–h-prune interaction with treatment of the MDA-
MB-h-prune #4 clone, as shown in co-immunoprecipita-
tion assays (Figure 5e). Moreover, we also used this
speciﬁc peptide (with the scrambled peptide control) to
Figure 5 Inhibition of cell motility in MDA-MB-435 breast cancer cells overexpressing h-prune. (a) MDA-MB-435-c100 and stable h-
prune-overexpressing MDA-MB-h-prune clones #3 and #4 cells treated with 50mM IC261 and 8 mM dipyridamole, as indicated, for 8
and 24 h, respectively. A Boyden chamber-like cell motility assay was used in the presence of 0.5% FCS, expressed as number of cells
counted under the microscope (means, ±s.d., from ﬁve independent experiments, each carried out in duplicate). *P¼ 0.002 (Student’s
t-test; MDA-MB-h-prune clones #3 and #4 versus MDA-MB-h-prune clones #3 and #4 with IC261). (b) As (a) with stable h-prune-
overexpressing MDA-MB-h-prune clones #4 and suboptimal concentrations of IC261 and dipyridamole separately and together, as
indicated. No signiﬁcant additive effects were seen. (c and d) Effects of speciﬁc competitive cell-permeable peptide (c) and scrambled
control peptide (d) on nm23-H1 phosphorylation. Nm23 was incubated with CKI and increasing amounts of the peptides, as indicated,
and nm23-H1 phosphorylation was followed using [g32P]-ATP. (e) MDA-MB-435-c100 cells were treated with the indicated peptides
for 24 h, with the cell extracts immunoprecipitated with the anti-h-prune polyclonal antibody. In the presence of the speciﬁc cell-
permeant peptide, nm23 was not detectable in the immunoprecipitates, as revealed by the use of the unpuriﬁed K73 anti-nm23
antibody. (f) As (a), with MDA-MB-h-prune clone #4 and MDA-MB-435 c100 cells treated the speciﬁc and scrambled peptides. The
speciﬁc cell-permeant peptide blocked the h-prune-overexpression-dependent cell motility in a dose-dependent manner. (g) PDE
activity measured in total protein lysates from MDA-MB-h-prune clone #4 and MDA-MB-435 c100 cells treated with vehicle or with
50 mM IC261. *P¼ 0.001 (Student’s t-test; MDA-MB-h-prune clone #4 versus MDA-MB-prune clone 4# treated with IC621).
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treat the MDA-MB-435-c100 wild-type cells and the
MDA-MB-h-prune #4 cells that were subsequently
assayed for cell motility (as above). Here, with the
speciﬁc peptide, the cell motility was reduced in the
h-prune-overexpressing clone in a dose-dependent man-
ner; neither the scrambled peptide nor the MDA-MB-
435-c100 wild-type cells showed any effects (Figure 5f).
This thus indicates that by speciﬁcally impairing nm23
phosphorylation, and consequently nm23–h-prune com-
plex formation, by the use of this speciﬁc peptide,
similar decreases in the motility of MDA-MB-h-prune
#4 cells were seen when compared to the direct
inhibition of CKI with IC261 (Figures 5a–f).
Taken together, these ﬁndings demonstrate the
importance of the formation of the protein complex
between h-prune and nm23 for the induction of cell
motility and the potential to use these two independent
agents to impair this process.
IC261 decreases the cAMP-PDE activity of the
MDA-MB-h-prune overexpressing cells
To determine whether the IC261 inhibition of the
cellular motility induced by h-prune overexpression is
due to a direct inhibition of the h-prune cAMP-PDE
activity, we initially tested this activity of the recombi-
nant h-prune protein in the presence of IC261: the
h-prune PDE activity was not affected (data not shown).
Therefore, as it has been previously reported that the
nm23–h-prune interaction can stimulate the h-prune
PDE activity in vitro (D’Angelo and Zollo, 2004), we
asked if IC261 treatment of the MDA-MB-h-prune #4
clone would inhibit h-prune PDE activity. These cells
show an increased total cAMP-PDE activity over the
MDA-MB-435-c100 wild-type cells (D’Angelo and
Zollo, 2004). Indeed, here in the presence of IC261,
the increase of total cAMP-PDE activity due to the h-
prune overexpression in these MDA-MB-h-prune #4
cells was lost, while the total cAMP-PDE activity of the
wild-type cells was not affected (see Figure 5g). This
thus suggests that the nm23–h-prune interaction has a
leading role in the h-prune cAMP-PDE activity in breast
cancer cells. Of note, this disruption of the nm23–
h-prune interaction also affects the cellular localization
of h-prune, as described in the Supplementary material
(see Supplementary Figures 4SA and B).
Discussion
Protein–protein interactions are essential processes that
occur during cell homeostasis, leading to the formation
of protein complexes within the networks of their
actions. H-prune- and nm23-interacting proteins have
been evolutionarily conserved in the vertebrate species,
including Homo sapiens, Mus musculus, D. rerio and X.
laevis. The principal ﬁnding of the present study is the
regulation of nm23 in the cell environment as part of the
CKI signaling cascade, whereby nm23 is phosphorylated
by the CKI family, which results in the modulation of its
interaction with h-prune. Nm23 and h-prune bind
together through the nm23 C-terminal domain, where
three independent point mutations in conserved serine
residues impair the interaction.
When a recombinant CKI enzyme was used to
phosphorylate nm23 in vitro, two modiﬁcations were
detectable by MRM mass spectrometry analysis, S122
and S125. While S122 is a residue that is also
phosphorylated by CKII in vitro on both nm23-H1 and
nm23-H2, to date there have been no reports describing
the phosphorylation on S125. Serine auto-phosphoryla-
tion mostly on S44, is accounting for only 0.2% of the
total auto-phosphorylation (Bominaar et al., 1994). We
have thus concluded that CKI is responsible for the S125
phosphorylation of nm23, as it is the only source of
phosphate known for this residue, while for position
S122, we cannot, at present, fully exclude a contribution
of auto-phosphorylation. Through in vitro kinase assays
we were also able to determine that all of the CKI
isoforms tested, namely a1, d, e, g3, can phosphorylate
nm23-H1, with CKIe as the most active isoform on
nm23-H1 (see Figures 2b and c).
In the context of the nm23–h-prune interaction, it
appears that phosphorylation on S125, S122 and S120
are all necessary, because in the presence of individual
point mutations in each of these residues the interactions
with h-prune were impaired (Figure 2d). However, we
found only two phosphorylated serines (S125, S122)
in vitro, which suggests to us that the S120 modiﬁcation
occurs in a transient manner, and maybe for the priming
of the phosphorylation of a downstream residue.
Similarly, in vivo in mammalian cells, nm23-H2 (the
more suitable protein to be analysed by triptic digestion)
was phosphorylated on S125 and on either S120 or
S122; again, transient phosphorylation on S120 cannot
be excluded, and this phosphorylation could be im-
portant to enhance the acid context that is necessary for
CKII phosphorylation on S122 (Meggio et al., 1993). A
recent study has also shown that autophosphorylation
of the nm23-H1-S120G protein corrected its folding
defect (Mocan et al., 2007). But what fraction of the
nm23 proteins is phosphorylated in living cells, and how
is this fraction is regulated in response to different
stimuli are still open questions.
We were not able to detect a change in nm23
phosphorylation status with CKII, AMPK or PKA
inhibitors, and the CKII inhibitor DMAT did not
impair the binding of nm23 with h-prune. However, it is
of note that nm23-H1 phosphorylation on S122 by
AMPKa1 has been reported as a way of regulating the
interaction of these two proteins in liver (Crawford
et al., 2006). As this appears contrary to the results
presented in Figure 4f for AMPK inhibition here, we
believe that this could be ascribed to the different
cellular types and models used (that is, liver versus
breast).
Our analyses with the use of IC261, has revealed that
nm23 is constitutively phosphorylated by these kinases
in breast cancer cells, thus providing an anti-motility
activity in a breast cancer cell model (MDA-MB-435).
The absence of an effect of IC261 on the wild-type
MDA-MB-435-c100 breast cancer cell line (Figure 5a)
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indicates that its effects are limited to an inhibition of
cell motility induced by h-prune or by the formation of
the nm23H1–h-prune complex. We chose the MDA-
MB-h-prune #3 and MDA-MB-h-prune #4 cell lines
that retain more balanced expression levels of the two
proteins (nm23 and h-prune) as our model of cell
motility induced by the formation of the nm23H1–h-
prune complex (Figure 5a).
Figure 6 illustrates in summary our model of the
function of the nm23H1–h-prune complex, where we
hypothesize that the formation of this complex impairs
the level of free nm23 that can function as an anti-
metastatic protein, although this phenomenon repre-
sents only a part of the mechanisms beneath the
increased cell motility induced by h-prune overexpres-
sion. Of note, the ﬁnding that IC261 fully blocks
the increase in PDE activity induced by h-prune raised
the possibility that the formation of the nm23–h-prune
complex has a role in the cAMP-PDE enzymatic activity
of h-prune. Indeed, it appears that IC261 decreases the
h-prune PDE activity indirectly through its inhibition of
h-prune binding to nm23, impairing the serine phos-
phorylation of nm23 and resulting in a lowering of the
cell motility to the levels seen in the control MDA-MB-
435-c100 wild-type cell line. Thus, the model proposed
implies that the nm23–h-prune complex is formed to
increase the activation of the h-prune cAMP-PDE
activity (see model in Figure 6). This protein complex
that is necessary for h-prune activity can, in turn, be
regulated by the other proteins in the cellular context,
possibly in terms of protein kinases or additional protein
binders, which can control h-prune activity and which
might also compete for h-prune binding with nm23.
Thus, a question arises whether the effects of IC261 can
be ascribed to direct or indirect actions against other
pathways that take part in the regulation of several
phosphodiesterases. We believe that this phenomenon
possesses, at least in our experimental model, a level of
speciﬁcity toward the formation of the nm23–h-prune
protein complex and its induction of cell motility. The
model proposed here involves only the h-prune protein
complex with nm23-H1, and it does not fully unravel the
relationship with the complex quaternary structure of
nm23-H1, which is known to form homo-oligomers and
hetero-oligomers (Heo et al., 1997). However, evidence
reported here does show that h-prune binds the
hexameric structures of nm23-H1, which is known to
be correlated to its anti-motility function and negatively
inﬂuenced by h-prune, and that this interaction is
controlled by CKI phosphorylation.
An important biological function of the CKI family is
a regulatory role in the Wnt/Frizzled/b-catenin pathway
(Gao et al., 2002; Hino et al., 2003).
At this time, only the data reported by Kobayashi
et al. (2006) and Garzia et al. (2006) link h-prune to
GSK3-b, a protein involved in the Wnt activation
pathway, and to cell migration. Our ﬁndings show that
IC261 impairs cell motility, thus raising the hypothesis
that h-prune, nm23 and CKIe, the last of which has
already been found to be involved in the modulation of
the signaling of dishevelled (Cong et al., 2004), have
roles in the Wnt pathway. These hypotheses might thus
open up new aspects of the migration-based mechanism
that involves h-prune as an important actor and of the
physiopathological functions of h-prune within the
complex with nm23 in cancer metastasis formation.
Materials and methods
Plasmid construction and protein expression
The plasmids GFP-prey_H1A (nm23-H1 aa 1–80), GFP-
prey_H1B (nm23-H1 aa 71–152), GFP-prey_H1C (nm23-H1
aa 41–82) encode three overlapping regions of the nm23-H1
Figure 6 Model for the h-prune and nm23-H1 interactions in breast cancer cells overexpressing h-prune. CKI and an ‘X’ serine
phosphatase factor are responsible for the balance between the amounts of the proteins in either a ‘complex’ or as ‘noncomplexed’. The
complex formation between h-prune and nm23 is one of the ﬁrst events to occur together with h-prune overexpression, which leads to
an increase in cell motility that is induced by the h-prune cAMP-PDE activity. Complex formation is necessary for the functional
activation of h-prune cAMP-PDE. Three independent agents (IC261, the permeable peptide and dipyridamole) have been identiﬁed as
inhibiting cancer progression upon h-prune overexpression.
Nm23–h-prune complex formation and cellular motility
L Garzia et al
10
Oncogene
protein as NLS-GFP/GST-nm23-H1-RevNES fusions. Plas-
mid p_prune-RevM10-BFP encodes a nucleolar anchored
fusion protein composed of h-prune and a NES deﬁcient
HIV-1 Rev-BFP fusion (BFP-prune_bait) (Knauer and Stau-
ber, 2005). Plasmids were constructed by PCR ampliﬁcation
and cloning into pNLS-GFP/GST-RevNES or pRevM10-
BFP, as described previously (Knauer and Stauber, 2005).
Nm23 from X. laevis was obtained from total RNA that was
extracted from unfertilized eggs using a standard reverse
transcriptase–PCR protocol. The nm23-speciﬁc sequence was
ampliﬁed with speciﬁc primers (available upon request) and
cloned into the HA-pcDNA vector (Invitrogen, Carlsbad, CA,
USA). The same strategy was applied to nm23 cloning from D.
rerio, C. elegans and D. melanogaster, using total RNA from
48-h embryos, adult worms and adult ﬂies, respectively. The
cDNA coding for nm23-H1-S120G, and S122P and S125A
were obtained through standard methods of site-directed
mutagenesis on wild-type sequences cloned in HA-pCDNA
and pFastBacHta vectors (Invitrogen), using the Quick-
Change III Kit (Stratagene, La Jolla, CA, USA). Cloning of
human CKId and CKIe were performed by standard
molecular biology protocols, with total RNA from HeLa cells
retrotranscribed with iScript (Biorad, Hercules, CA, USA)
following the manufacturer’s protocol. CKId and CKIe were
ampliﬁed by PCR with the following primers:
CKI-delta_eco_for CGGGAATTCATGGAGCTGAGAG
TCGGGAACAG; CKI-delta_xho_rev CGGCTCGAGTCCT
CGGTGCACGACAGACTG; and CKI-epsilon_hind_for
CGGAAGCTTATGGAGCTACGTGTGGGGAACAAG; CKI-
epsilon_hind_rev CGGAAGCTTTCGCTTCCCGAGATGGTC
AAATGGC.
The cDNA were then inserted into the pReyzo expression
vector digested with the appropriate restriction enzymes. The
protein expression and puriﬁcation of h-prune and wild-type
nm23 and its mutants were performed with a baculovirus
expression system (Invitrogen) and Ni-NTA afﬁnity resin, as
described previously (Garzia et al., 2003). Speciﬁc and scrambled
cell penetrating peptides were synthesized by PRIMM (Milan,
Italy); the sequences are shown in Figures 5c and d.
Gel filtration assay
Gel ﬁltration assays were performed on an Atka FPLC system
(Amersham Biosciences, Piscataway, NJ, USA) using an Amer-
sham Biosciences Superdex 200 PC 3.2/30 column equilibrated and
eluted in 50mM Tris buffer, pH 7.5, containing 150mM NaCl.
Samples of nm23-H1 (50mg) that were nonphosphorylated or were
phosphorylated by CK1 kinase as described previously (Garzia
et al., 2003) were dissolved in an appropriate volume of buffer to a
ﬁnal concentration of 10mM. All experiments were carried out at
25 1C with a ﬂow rate of 0.5mlmin1. The column was calibrated
under the same conditions with proteins of knownmolecular mass:
bovine albumin (66kDa), carbonic anhydrase (30kDa) and
cytochrome C (11kDa).
The nm23-H1 was then reduced in 300mM Tris–HCl, pH
8.5, 1.25mM EDTA, 6M guanidinium chloride by incubation
with dithiothreitol at a 10:1 molar excess over the total –SH
groups (37 1C, 2 h, nitrogen atmosphere). The free cysteine
residues were alkylated with iodoacetamide at a 5:1 molar
excess over the total –SH groups (room temperature, 30min,
in the dark, nitrogen atmosphere). Excess of reagents were
removed from protein samples by gel ﬁltration on PD10
Sephadex G25 columns. Enzymatic digestion was carried out
with trypsin in 50mM ammonium bicarbonate, pH 8.5, at an
enzyme:substrate ratio of 1:50 (w/w) (37 1C for 18 h).
PDE activity assay with cAMP as substrate
PDE activity was measured as described previously (D’Angelo
et al., 2004). See also Supplementary material.
MALDI–TOF mass spectrometry, nanoLC-mass spectro-
metry, cell-based techniques, in vitro phosphorylation, inter-
action assays and phospho-nm23 antibody generation, are
available as Supplementary material.
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